FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:949-951 March 1, 2007 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Shrestha, M. P. PubMed Citation

Large outbreaks of hepatitis E virus (HEV) infection were first recognized as a distinct clinical entity in the early 1980s.^1,2 Outbreaks continue and involve thousands of patients in certain geographic regions of the world, including the Indian subcontinent, northwest China, and the Central Asian Republics (the former Soviet Union) — areas where HEV infection is endemic.³ HEV is transmitted predominantly through the fecal–oral route, and most reported outbreaks of infection have been related to the consumption of fecally contaminated drinking water; person-to-person transmission of the disease appears to be uncommon. There is a high attack rate in adults and a . . . [Full Text of this Article]

Source Information

From the Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta.

This article has been cited by other articles:

• Hossain, N, Shamsi, T, Kuczynski, E, Lockwood, C J, Paidas, M J (2009). Liver dysfunction in pregnancy: an important cause of maternal and perinatal morbidity and mortality in Pakistan. Obstet Med 2: 17-20 [Abstract] [Full Text]  
• (2007). Recombinant Hepatitis E Vaccine Safe and Efficacious. JWatch Infect. Diseases 2007: 2-2 [Full Text]